User profiles for Ritu Singh

Ritu Singh

Assistant Professor, Department of Environmental Science, Central University of Rajasthan …
Verified email at curaj.ac.in
Cited by 1992

Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to …

AK Singh, A Singh, A Shaikh, R Singh… - Diabetes & Metabolic …, 2020 - Elsevier
Background and aims No drugs are currently approved for Coronavirus Disease-2019 (COVID-19),
although some have been tried. In view of recent studies and discussion on …

Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India

AK Singh, R Singh, SR Joshi, A Misra - Diabetes & Metabolic Syndrome …, 2021 - Elsevier
Background and aims There are increasing case reports of rhino-orbital mucormycosis in
people with coronavirus disease 2019 (COVID-19), especially from India. Diabetes mellitus (…

[HTML][HTML] Therapeutic and Medicinal Uses of Aloe vera: A Review

PK Sahu, DD Giri, R Singh, P Pandey, S Gupta… - Pharmacology & …, 2013 - scirp.org
The plant Aloe vera is used in Ayurvedic, Homoeopathic and Allopathic streams of medicine,
and not only tribal community but also most of the people for food and medicine. The plant …

Hydroxychloroquine in patients with COVID-19: A Systematic Review and meta-analysis.

AK Singh, A Singh, R Singh, A Misra - Diabetes & metabolic syndrome …, 2020 - Elsevier
Backgrounds and aims The role of hydroxychloroquine (HCQ) in the treatment of COVID-19
is not fully known. We studied the efficacy of HCQ compared to the control in COVID-19 …

Prevalence of co‐morbidities and their association with mortality in patients with COVID‐19: a systematic review and meta‐analysis

AK Singh, CL Gillies, R Singh, A Singh… - Diabetes, Obesity …, 2020 - Wiley Online Library
Aim To estimate the prevalence of both cardiometabolic and other co‐morbidities in patients
with COVID‐19, and to estimate the increased risk of severity of disease and mortality in …

Molnupiravir in COVID-19: A systematic review of literature

AK Singh, A Singh, R Singh, A Misra - Diabetes & Metabolic Syndrome …, 2021 - Elsevier
Background and aims Molnupiravir is a newer oral antiviral drug that has recently been
tested in COVID-19. We aim to conduct a systematic review of literature to find out the efficacy …

Role of corticosteroid in the management of COVID-19: A systemic review and a Clinician's perspective

AK Singh, S Majumdar, R Singh, A Misra - Diabetes & Metabolic Syndrome …, 2020 - Elsevier
Background and aims Interest in corticosteroid therapy in COVID-19 has been rekindled
after the results from Randomized Evaluation of COVid-19 thERapY (RECOVERY) Trial. …

Remdesivir in COVID-19: A critical review of pharmacology, pre-clinical and clinical studies

AK Singh, A Singh, R Singh, A Misra - Diabetes & Metabolic Syndrome …, 2020 - Elsevier
Background & aims Remdesivir is a broad spectrum anti-viral drug that has shown to inhibit
SARS-CoV-2, in vitro and in vivo. In absence of any effective treatment for SARS-CoV-2 …

Effects of zinc-oxide nanoparticles on soil, plants, animals and soil organisms: A review

…, A Behal, SN Sushkova, S Mandzhieva, R Singh… - Environmental …, 2018 - Elsevier
Zinc-oxide nanoparticles are being used in a wide range of commercial applications and
are therefore expected to find their way into the soil ecosystem. Problems concerning Zinc-…

Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19

AK Singh, R Singh - Diabetes research and clinical practice, 2020 - Elsevier
Hyperglycemia with or without blood glucose in diabetes range is an emerging finding not
uncommonly encountered in patients with COVID-19. Increasingly, all evidence currently …